Cystic fibrosis gene therapy trials and tribulations

Trends in Molecular Medicine

Volumn 7, Issue 11, 2001, Pages 488-

  Caplen, Natasha J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

ADENOVIRUS; AUTOSOMAL RECESSIVE DISORDER; CLINICAL TRIAL; CYSTIC FIBROSIS; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HUMAN; INFLAMMATION; MOLECULAR CLONING; MULTICENTER STUDY; NOTE;

EID: 0034764808     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1471-4914(01)02168-2     Document Type: Note

References (3)

1. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications
2. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium
3. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis